Study drug levels in critically ill children
Part of Infections clinical trials.
This trial measures how anti-infective medicines move through a child’s body while they are in the hospital or during follow-up. The goal is to better understand dosing and drug exposure in critically ill children.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a child who is critically ill and needs an anti-infective medicine
- The medicine must be one of these: certain antibiotics, antifungals, or antivirals
- The medicine class includes β-lactam antibiotics, aminoglycosides, glycopeptides, fluoroquinolones, or other listed anti-infectives
- You are able to participate during hospital stay or follow-up time
- You and your parents/guardians do not refuse collection of study data
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how antibiotics move through the body in adults who are hospitalized. By measuring antibiotic levels in blood (or other body samples), the team may better understand dosing for safer, more effective treatment.
This trial looks at how children with severe bacterial infections that start outside the hospital are treated in the pediatric intensive care unit. It helps doctors learn more about these infections to improve care for kids.
This study looks at whether giving common antibiotics in certain dose schedules (either through a drip over time or continuously) is done in a way that fits pediatric intensive care needs. It may help improve antibiotic treatment for children who are very sick and need antibiotics.
This trial enrolls children in the pediatric intensive care unit (PICU) who have a severe infection. It aims to better understand germs and drug resistance so future treatments can be more effective.
This trial measures how the study medicines move through the body and how they affect the child in the Pediatric Cardiac Intensive Care Unit. It may help doctors choose safer and better dosing for critically ill children.
This trial tests a personalized dosing approach for certain antibiotics (amoxicillin-clavulanic acid, piperacillin-tazobactam, and meropenem) in hospitalized children with serious infections. The goal is to adjust the dose based on blood tests to make sure each child gets the right amount of medicine.
Hear when a new Pediatric Intensive Care Unit trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.